Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02463682 · ClinicalTrials.gov registry record · NA
Early Feasibility Study of Zone-MPC and HMS With DiAs in the Outpatient Setting
A NA study, sponsored by Sansum Diabetes Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT02463682 is a NA study that has completed, run by Sansum Diabetes Research Institute. The registered enrollment target is 9 participants.
The verdict
NCT02463682, a NA study, has completed, sponsored by Sansum Diabetes Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
This is a feasibility study of an artificial pancreas (AP) system with our previously validated Zone-MPC and Health Monitoring System (HMS) algorithms (ClinicalTraisl.gov: NCT01929798) integrated into the Diabetes Assistant (DiAs) system.
Interventions
- DEVICE CGM and Insulin Pump
- DEVICE Closed-Loop Control System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2015-05 |
| Est. Completion | 2015-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02463682
The ClinicalTrials.gov registry entry for NCT02463682 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sansum Diabetes Research Institute, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CGM and Insulin Pump is the first listed.
NCT02463682 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02463682 about?
NCT02463682 is a clinical study titled "Early Feasibility Study of Zone-MPC and HMS With DiAs in the Outpatient Setting". This is a feasibility study of an artificial pancreas (AP) system with our previously validated Zone-MPC and Health Monitoring System (HMS) algorithms (ClinicalTraisl.gov: NCT01929798) integrated into the Diabetes Assistant (DiAs) system.
What is the current status of trial NCT02463682?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2015-05. Estimated completion is 2015-10.
What interventions are being tested in trial NCT02463682?
The interventions under investigation include: CGM and Insulin Pump (DEVICE), Closed-Loop Control System (DEVICE).
Who is sponsoring clinical trial NCT02463682?
This trial is sponsored by Sansum Diabetes Research Institute, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.